ReviewPulmonary pharmacology & therapeutics2021

Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19.

Marie Fisk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.